Webinar for CIBRN Dermatology Subgroup, presented by Dr. Gordon Searles, Dr. Ronald Vender & Dr. Mark Kirchhof, Thurs, Dec 8, 7:00 pm EST

Please join Dr. Gordon Searles, Dr. Ronald Vender and Dr. Mark Kirchhof for an in-depth discussion of CIBRN Question #5 and Question #6 surrounding the implications of the evolving Biosimilar landscape on clinical practice and patient health in Canada.

This webinar is intended for the CIBRN Dermatology subgroup and is scheduled for Thursday, December 8th, 7:00-8:00pm EST. See instructions below:

Step 1: To join the audio portion:
Dial toll-free:  1-866-830-9434
Enter Participant Code: 7994216

Step 2: To join the web portion:
Click on link: https://studio7communications.adobeconnect.com/cibrn_dermatology/
Select ‘Next’
Select ‘Guest’
Enter your name
Select ‘Enter’

Prior to the webinar, you are invited to visit the CIBRN community on Sosido to review the questions & responses and to reply with your personal clinical perspectives. The webinar will be recorded and archived for future viewing by the CIBRN community.

If you have any comments or questions, please contact me at your convenience.

Paul Abbass
LEGITIMED INC.
Email: paul.abbass@legitimed.com

—————-
If you have never attended an Adobe Connect meeting before:

Test your connection: https://studio7communications.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html